National Pharmaceutical Pricing Authority (NPPA) has issued notices to Cipla for overpricing of two drugs demanding an amount of Rs 47.70 crore in respect of the drug Salbutamol and an amount of Rs 25.46 crore in respect of the drug Ciprofloxacin.
The total estimated overcharged amount, including interest, by various pharma companies since the inception of the NPPA in 1997 is a whopping Rs 2,208.35 crore. But so far, the Authority could recover a paltry Rs 202.20 crore from this and is fighting litigations in various courts with the companies to recover the rest of the sum.
